Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

Printer-friendly version
TitreIndolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Type de publicationJournal Article
Nouvelles publications2016
AuteursKaminska KK, Bertrand HC, Tajima H, Stafford WC, Cheng Q, Chen W, Wells G, Arner ESJ, Chew E-H
JournalOncotarget
Volume7
Fascicule26
Pagination40233-40251
Année de publication06/2016
DOI10.18632/oncotarget.9579
Importer un fichierOncotarget
Unité de rattachement: 
UMR 7203
Equipe de rattachement 7203: 
Equipe 1